Skip to main content

Mor George Adi's Form 4 filing

Chemomab Therapeutics Ltd. (CMMB) · filed Jan 5, 2023

Accession no.
0001178913-23-000076
Filed
Jan 5, 2023
Trade date
Oct 28, 2016-Jan 3, 2023
Filing delay
2,260 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 2 non-derivative transactions and 2 derivative transactions. Open-market sales total $69.4K. It was filed 2260 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Mor George AdiCIK 0001851069Director, Officer (Chief Scientific Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 3, 2023American Depositary SharesSSaleDisposed−7,700$5.03−$38,731317,075Direct
Jan 3, 2023American Depositary SharesSSaleDisposed−6,100$5.03−$30,683251,147Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 15, 2018American Depositary SharesAGrant or awardAcquired+131,698$0.00$0131,698DirectDuplicate filing
Oct 28, 2016American Depositary SharesAGrant or awardAcquired+33,725$0.00$033,725IndirectDuplicate filing

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)